(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early. “If we find it early, we have a lot more options in treating it,” said Dr.
The World Health Organization estimates that around 900,000 people each year die of colorectal ... that CEA screening lacks sensitivity, missing about half of CRC recurrences 2. Cancer researchers ...
Colorectal cancer (CRC) is the third most common cancer globally, with more than 1.9 million new cases reported in 2020, according to World Cancer Research Fund. The US Preventive Services Task Force ...